Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Neutral-Pressure Needleless Connector Prevents Blood Reflux

By HospiMedica International staff writers
Posted on 18 Aug 2010
A neutral-pressure connection device prevents all types of blood reflux in a catheter, and it can be used for the administration of blood and fluids to all patients, including pediatric and immune-compromised patients.

The Clave Neutron neutral-pressure needleless connector is a normally closed, bidirectional connector that incorporates a unique silicone valve within the fluid path. More...
The valve prevents fluid displacement, both positive and negative at all times, including when the device is accessed. The device may also be used with power injector procedures up to 10 mL per second of contrast media and a maximum pressure of 2413 kPa. The device incorporates a pre-slit septum valve and internal cannulae, which are used to transfer fluid to the patient's catheter. The two functional components also prohibit bacterial transfer and bacterial ingress, as well as independently reduce catheter hub and tip bacterial colonization. The device also passively aids in the prevention of needle-stick injury, since needles cannot be introduced into the system during use.

The device incorporates a technology that prevents fluid displacement resulting from the connection or disconnection of a luer; from syringe plunger compression; from patient vascular pressure changes, such as coughing or sneezing; and from the intravenous (IV) solution container running dry. The Clave Neutron device is a product of ICU Medical (San Clemente, CA, USA), and has been approved by the U.S. Food and Drug Administration (FDA). The company expects to conduct expanded clinical beta testing of the device with select customers in the third quarter of 2010.

As a neutral-pressure device, the use of the Clave Neutron helps deal with concerns about the safety of positive displacement needleless connectors and their possible connection to higher rates of device associated bloodstream infections (BSI). Following three reports of deaths associated with BSI and positive displacement needleless connectors, the FDA ordered manufacturers of positive displacement connectors to conduct a post-market surveillance study on the safety of these devices.

Fluid displacement in syringe plunger rebound occurs when a flush has been done using a standard syringe; once the syringe is emptied, the clinician has the ability to compress the syringe plunger in an effort to infuse all available solutions, which once released by the clinician's hand, will rebound and cause negative fluid displacement.

Related Links:
ICU Medical


Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Infant Incubator
OKM 801
Newborn Hearing Screener
ALGO 7i
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.